Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 8 | 2025 | 737 | 1.120 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 3 | 2022 | 246 | 0.810 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2023 | 144 | 0.740 |
Why?
|
| Histone Deacetylase 2 | 2 | 2023 | 14 | 0.720 |
Why?
|
| Heart Diseases | 2 | 2023 | 511 | 0.680 |
Why?
|
| Myocytes, Cardiac | 8 | 2024 | 652 | 0.660 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2021 | 175 | 0.640 |
Why?
|
| Heart Atria | 5 | 2025 | 336 | 0.640 |
Why?
|
| Prostatic Neoplasms | 5 | 2023 | 1577 | 0.610 |
Why?
|
| Neovascularization, Pathologic | 2 | 2018 | 257 | 0.590 |
Why?
|
| Spectrin | 1 | 2018 | 61 | 0.560 |
Why?
|
| Thrombospondin 1 | 1 | 2016 | 23 | 0.510 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 508 | 0.510 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2016 | 78 | 0.500 |
Why?
|
| Calpain | 2 | 2024 | 43 | 0.380 |
Why?
|
| Calcium Signaling | 3 | 2022 | 255 | 0.340 |
Why?
|
| G-Protein-Coupled Receptor Kinase 3 | 2 | 2023 | 9 | 0.340 |
Why?
|
| Signal Transduction | 5 | 2023 | 4710 | 0.330 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 397 | 0.300 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2018 | 98 | 0.280 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4684 | 0.280 |
Why?
|
| Fibrosis | 3 | 2025 | 421 | 0.280 |
Why?
|
| Mice | 15 | 2025 | 18478 | 0.270 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 2022 | 154 | 0.250 |
Why?
|
| Receptors, Cell Surface | 2 | 2025 | 450 | 0.250 |
Why?
|
| Membrane Proteins | 3 | 2024 | 1609 | 0.240 |
Why?
|
| Myocardium | 2 | 2020 | 906 | 0.230 |
Why?
|
| Proteomics | 3 | 2025 | 596 | 0.230 |
Why?
|
| Animals | 17 | 2025 | 34804 | 0.220 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2024 | 25 | 0.210 |
Why?
|
| Androgen Antagonists | 3 | 2023 | 133 | 0.210 |
Why?
|
| Muscle Proteins | 3 | 2024 | 404 | 0.210 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2024 | 73 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2025 | 861 | 0.210 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2024 | 106 | 0.200 |
Why?
|
| Calcium | 3 | 2023 | 1079 | 0.190 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2021 | 5 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 2057 | 0.180 |
Why?
|
| Calcitonin | 1 | 2020 | 32 | 0.170 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 2447 | 0.170 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 477 | 0.170 |
Why?
|
| Pedigree | 1 | 2024 | 1719 | 0.170 |
Why?
|
| Paracrine Communication | 1 | 2020 | 70 | 0.170 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2020 | 67 | 0.170 |
Why?
|
| Heart Failure | 3 | 2024 | 2401 | 0.160 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 241 | 0.160 |
Why?
|
| Fibrinogen | 1 | 2020 | 157 | 0.160 |
Why?
|
| Regeneration | 1 | 2021 | 225 | 0.150 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2019 | 16 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 501 | 0.150 |
Why?
|
| Disease Progression | 3 | 2024 | 2227 | 0.150 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 123 | 0.140 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 123 | 0.140 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 3682 | 0.140 |
Why?
|
| Protein Precursors | 1 | 2019 | 156 | 0.140 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 58 | 0.140 |
Why?
|
| Ankyrins | 1 | 2018 | 96 | 0.140 |
Why?
|
| Dependovirus | 1 | 2019 | 154 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 347 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 232 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 1061 | 0.130 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2016 | 38 | 0.120 |
Why?
|
| Heterografts | 1 | 2016 | 197 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2016 | 248 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2019 | 927 | 0.110 |
Why?
|
| Humans | 15 | 2024 | 132064 | 0.110 |
Why?
|
| Male | 13 | 2025 | 64938 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2016 | 260 | 0.110 |
Why?
|
| Adenocarcinoma | 2 | 2018 | 1017 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1668 | 0.100 |
Why?
|
| Models, Biological | 1 | 2016 | 1443 | 0.090 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 315 | 0.080 |
Why?
|
| Mice, SCID | 2 | 2021 | 603 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 4757 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 2952 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2025 | 3043 | 0.060 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2025 | 21 | 0.060 |
Why?
|
| Protein Interaction Maps | 1 | 2024 | 90 | 0.050 |
Why?
|
| Proteolysis | 1 | 2024 | 195 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 237 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1964 | 0.050 |
Why?
|
| Action Potentials | 1 | 2025 | 491 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 420 | 0.050 |
Why?
|
| Proteome | 1 | 2024 | 279 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3865 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2023 | 215 | 0.040 |
Why?
|
| Receptors, Calcitonin | 1 | 2020 | 21 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2023 | 332 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2020 | 121 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1045 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2024 | 933 | 0.040 |
Why?
|
| Protein Phosphatase 1 | 1 | 2019 | 54 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 48 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2024 | 995 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 67 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 992 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 165 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 333 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2019 | 366 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 293 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 591 | 0.030 |
Why?
|
| Female | 5 | 2024 | 70664 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1882 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 193 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 679 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2020 | 1610 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2193 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 879 | 0.030 |
Why?
|
| Prostate | 1 | 2018 | 437 | 0.030 |
Why?
|
| Phenotype | 1 | 2025 | 4527 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2024 | 2442 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1282 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1899 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 3352 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2509 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 5010 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 28993 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 31571 | 0.010 |
Why?
|
| Child | 1 | 2023 | 25763 | 0.010 |
Why?
|